Clinical Implications of Residual Urine in Korean Benign Prostatic Hyperplasia (BPH) Patients: A Prognostic Factor for BPH-Related Clinical Events
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Purpose: Although post-void residual urine (PVR) is frequently utilized clinically in patients with benign prostatic hyperplasia (BPH), mainly because of its procedural simplicity, its role as a clinical prognostic factor, predictive of treatment goals, is still under much dispute. We investigated the predictive value of PVR for BPH-related clinical events including surgery, acute urinary retention (AUR), and admission following urinary tract infection (UTI). Methods: From January to June of 2006, patients over 50 years of age who were diagnosed with BPH for the first time at the outpatient clinic and were then treated for at least 3 years with medications were enrolled in this study. The variables of patients who underwent surgical intervention for BPH, had occurrences of AUR, or required admission due to UTI (Group 1, n=43) were compared with those of patients who were maintained with medications only (Group 2, n=266). Results: Group 1 had a significantly higher PVR, more severe symptoms, and a larger prostate at the time of the initial diagnosis in both the univariate and the multivariate analysis. In the 39 patients who underwent BPH-related surgery, although there was a significant change in Qmax at the time of surgery (mean, 13.1 months), PVR and the symptom score remained unchanged compared with the initial evaluation. In the receiver-operating characteristic curve analysis, the area under the curve of Group 1 was in the order of prostate volume (0.834), PVR (0.712), and symptom score (0.621). When redivided by arbitrarily selected PVR cutoffs of 50 mL, 100 mL, and 150 mL, the relative risk of clinical BPH progression was measured as 3.93, 2.61, and 2.11. Conclusions: These data indicate that, in the symptomatic Korean population, increased PVR at baseline is a significant indicator of BPH-related clinical events along with increased symptom score or prostate volume.
Abstract
Purpose: Although post-void residual urine (PVR) is frequently utilized clinically in patients with benign prostatic hyperplasia (BPH), mainly because of its procedural simplicity, its role as a clinical prognostic factor, predictive of treatment goals, is still under much dispute. We investigated the predictive value of PVR for BPH-related clinical events including surgery, acute urinary retention (AUR), and admission following urinary tract infection (UTI). Methods: From January to June of 2006, patients over 50 years of age who were diagnosed with BPH for the first time at the outpatient clinic and were then treated for at least 3 years with medications were enrolled in this study. The variables of patients who underwent surgical intervention for BPH, had occurrences of AUR, or required admission due to UTI (Group 1, n=43) were compared with those of patients who were maintained with medications only (Group 2, n=266). Results: Group 1 had a significantly higher PVR, more severe symptoms, and a larger prostate at the time of the initial diagnosis in both the univariate and the multivariate analysis. In the 39 patients who underwent BPH-related surgery, although there was a significant change in Qmax at the time of surgery (mean, 13.1 months), PVR and the symptom score remained unchanged compared with the initial evaluation. In the receiver-operating characteristic curve analysis, the area under the curve of Group 1 was in the order of prostate volume (0.834), PVR (0.712), and symptom score (0.621). When redivided by arbitrarily selected PVR cutoffs of 50 mL, 100 mL, and 150 mL, the relative risk of clinical BPH progression was measured as 3.93, 2.61, and 2.11. Conclusions: These data indicate that, in the symptomatic Korean population, increased PVR at baseline is a significant indicator of BPH-related clinical events along with increased symptom score or prostate volume.
참고문헌 (25)
- Emberton M, "Definition of at-risk patients: dynamic variables", BJU Int, 97(Suppl 2), pp.12~15 (2006)
- Xia SJ, "Characteristic pattern of human prostatic growth with age", Asian J Androl, 4, pp.269~271 (2002)
- Kolman C, "Distribution of post-void residual urine volume in randomly selected men", J Urol, 161, pp.122~127 (1999)
- Kok ET, "Risk factors for lower urinary tract symptoms suggestive of benign prostatic hyperplasia in a community based population of healthy aging men: the Krimpen Study", J Urol, 181, pp.710~716 (2009)
- Crawford ED, "Baseline factors as predictors of clinical progression of benign prostatic hyperplasia in men treated with placebo", J Urol, 175, pp.1422~1426 (2006)
- Kristal AR, "Race", ethnicity, obesity, health related behaviors and the risk of symptomatic benign prostatic hyperplasia: results from the prostate cancer prevention trial, 2007, pp.177, 1395~1400
- Jin B, "Ethnicity and migration as determinants of human prostate size", J Clin Endocrinol Metab, 84, pp.3613~3619 (1999)
- Oesterling JE, "Serum prostate-specific antigen in a community-based population of healthy Japanese men: lower values than for similarly aged white men", Br J Urol, 75, pp.347~353 (1995)
- Simforoosh N, "Accuracy of residual urine measurement in men:comparison between real-time ultrasonography and catheterization", J Urol, 158, pp.59~61 (1997)
- Bates P, "The standardization of terminology of lower urinary tract function", J Urol, 121, pp.551~554 (1979)
- Ball AJ, "The natural history of untreated“prostatism”", Br J Urol, 53, pp.613~616 (1981)
- Van Mastrigt R, "The prognostic value of bladder contractility in transurethral resection of the prostate", J Urol, 148, pp.1856~1860 (1992)
- Barry MJ, "Relationship of symptoms of prostatism to commonly used physiological and anatomical measures of the severity of benign prostatic hyperplasia", J Urol, 150(2 Pt 1), pp.351~358 (1993)
- Ruud Bosch JL, "Postvoid residual urine in the evaluation of men with benign prostatic hyperplasia", World J Urol, 13, pp.17~20 (1995)
- Cetinel B, "Update evaluation of benign prostatic hyperplasia: when should we offer prostatectomy?", Br J Urol, 74, pp.566~571 (1994)
- Bruskewitz RC, "Value of postvoid residual urine determination in evaluation of prostatism", Urology, 20, pp.602~604 (1982)
- Kranse R, "Weak correlation between bladder outlet obstruction and probability to void to completion", Urology, 62, pp.667~671 (2003)
- Bonde HV, "Residual urine in 75-year-old men and woman: a normative population study", Scand J Urol Nephrol, 30, pp.89~91 (1996)
- Birch NC, "Serial residual volumes in men with prostatic hypertrophy", Br J Urol, 62, pp.571~575 (1988)
- Memon A, "Use of residual fraction instead of residual volume in the evaluation of lower urinary tract symptoms", Tech Urol, 6, pp.26~28 (2000)
- Ku JH, "Residual fraction as a parameter to predict bladder outlet obstruction in men with lower urinary tract symptoms", Int J Urol, 16, pp.739~744 (2009)
- Kuo HC, "Clinical prostate score for diagnosis of bladder outlet obstruction by prostate measurements and uroflowmetry", Urology, 54, pp.90~96 (1999)
- Emberton M, "Symptom deterioration during treatment and history of AUR are the strongest predictors for AUR and BPH-related surgery in men with LUTS treated with alfuzosin 10 mg once daily", Urology, 66, pp.316~322 (2005)
- Reilly NJ, "The release of the clinical practice guideline: benign prostatic hyperplasia: diagnosis and treatment", Urol Nurs, 14, pp.37~ (1994)
- Roehrborn CG, "Can transabdominal ultrasound estimation of postvoiding residual (PVR) replace catheterization?", Urology, 31, pp.445~449 (1988)